… ) is a distinct subgroup of NSCLCs that is particularly responsive to EGFR tyrosine… clinical
outcome in patients with EGFR-mutated NSCLC who were treated with chemotherapy or EGFR …

… gene assay analysis for EGFR mutations in NSCLC, which … oncogene mutations may impact
the clinical outcomes of EGFR … can be identified in advanced EGFR mutated NSCLC using …

… NSCLC stratified by EGFR mutation status. The … clinical studies have suggested patients
with mutated EGFR have poorer responses to chemotherapy than patients with wild-type EGFR …

… IIIB/IV) NSCLC and the clinical outcomes associated with these mutations. Having identified
… all EGFR mutations represented by uncommon mutations, and to compare clinical outcomes…

… EGFR-TKI at the time of disease-progression on PFS [21]. Our study however, assessed the
clinical outcomes … Our findings highlight favourable outcomes in PPS if EGFRmut + NSCLC …

… exhibit different responsiveness to EGFR-TKIs and what are the potential mechanism for …
the clinical outcomes of EGFR-TKI treatment in patients with EGFR 19 del and L858R mutations …

… of EGFR TKIs by EGFR mutation status. The included studies were randomized trials that
compared EGFR … diagnosed advanced NSCLC with sensitizing EGFR mutations. In brief, we …

… compound EGFR mutation had properties which might be related to poor clinical outcome, …
survival (OS) of cases with simple and compound mutations ( Fig. 1 ). The median follow-up …

… This paper describes an updated literature search for clinical studies of erlotinib, gefitinib
and other EGFR TKIs in patients with EGFR mutation-positive NSCLC, and reports the results …

… We subsequently performed multiple-driver mutation and clinical-characteristic analyses of
… only able to compare clinical outcomes for the 640 patients with HER2 (n = 33), EGFR (n = …